Top States: CA | DC | FL | GA | MA | NC | NJ | NY | OH | TX | WA |

Revenue Cycle Inc. Forges Partnership with D3 Oncology Solutions for the Newly Launched SABRE Program

By :: Fri, 05 Aug 2011 04:59:19 -0400 EDT

stereotactic radiosurgeryAUSTIN, Texas, Aug. 5, 2011 (SEND2PRESS NEWSWIRE) — Revenue Cycle Inc. announces that it has forged a strategic collaboration with D3 Oncology Solutions for SABRE financial consulting and support. In this newly formed partnership, Revenue Cycle Inc. will research and educate D3 Oncology Solutions clients in proper coding, billing, documentation, and compliance for SABRE, D3′s comprehensive program that helps cancer centers safely and effectively implement a new SRS/SBRT (stereotactic radiosurgery/stereotactic body radiotherapy) program for improved patient outcomes.

“We’re proud to forge this strategic collaboration with D3 to facilitate and streamline the implementation of their SABRE program,” says Ron DiGiaimo, CEO of Revenue Cycle Inc. “The proliferation of radiosurgery in the US is a testimony to the associated benefits patients receive from this modality. We are excited to play a role in helping D3 expand this service line.”

Based in Austin, Texas and founded in 2002, Revenue Cycle Inc. (http://www.revenuecycleinc.com) is a medical and radiation oncology consulting resource for the oncology industry. It provides specialized, comprehensive services to healthcare providers including auditing, training, billing and coding, electronic medical record compliance, corporate vendor relations, cancer center development, and practice management. Revenue Cycle Inc.’s consultants and its affiliated companies streamline financial record-keeping, cut operational costs, maintain compliance with federal regulations, and improve profitability.

Founded in 2002, D3 (http://www.d3onc.com) is an affiliate of UPMC, an integrated global health enterprise headquartered in Pittsburgh and one of the leading health systems in the country. Its mission is to develop and deliver leading edge solutions that accelerate the quality, safety, efficiency, and outcomes of cancer patients’ care at radiation and medical oncology centers. D3 has assisted hundreds of cancer centers worldwide in delivering advanced radiation therapy.

Revenue Cycle Inc.’s on-site, hands-on education will include topics related to SRS/SBRT process of care, financial counseling, reference materials, billing and determination of covered diagnosis for requested SRS/SBRT procedures for each of the customer’s top payers. Revenue Cycle Inc. will provide a complete billing and coding guide to D3 Oncology Solutions customers and will assist in ensuring that initial cases stemming from this strategic collaboration are accurate and compliant. “Revenue Cycle’s consulting expertise will be invaluable in optimizing the success of our SABRE program,” says Kathy Lokay, president and CEO of D3 Oncology Solutions. “We look forward to working with them.”

For more information about Revenue Cycle Inc., visit http://www.revenuecycleinc.com or call 512.583.2000. For more information about D3 Oncology Solutions, visit http://www.d3onc.com or call 412.365.0710.

News Source: Revenue Cycle Inc. :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®. View all current news at: http://Send2PressNewswire.com .

More Information:

Press Release Copr. © Revenue Cycle Inc. (or “news source”) and Send2Press® Newswire. Permission granted for reproduction by news portals, aggregators and news indexes provided original attribution to this site and news source is retained. Cannot be used for commercial purposes/advertising or keyword marketing. All other rights reserved.

This press release has had 2,063 views so far.
http://www.send2press.com/newswire/2011-08-0805-001.shtml
 
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the "news source." The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this Web site) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or the Send2Press® Newswire service. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.